TY - JOUR
T1 - Moving toward generalizable NZ-1 labeling for 3D structure determination with optimized epitope-Tag insertion
AU - Tamura-Sakaguchi, Risako
AU - Aruga, Rie
AU - Hirose, Mika
AU - Ekimoto, Toru
AU - Miyake, Takuya
AU - Hizukuri, Yohei
AU - Oi, Rika
AU - Kaneko, Mika K.
AU - Kato, Yukinari
AU - Akiyama, Yoshinori
AU - Ikeguchi, Mitsunori
AU - Iwasaki, Kenji
AU - Nogi, Terukazu
N1 - Funding Information:
We are grateful to the beamline staff of the Photon Factory, Tsukuba, Japan for providing data-collection facilities and support. We thank Samuel Thompson for editing the manuscript and Professor Junichi Takagi for useful discussion. This work was performed in part under the Cooperative Research Program (Joint Usage/Research Center Program) of the Institute for Frontier Life and Medical Sciences, Kyoto University, under the Collaborative Research Program of the Institute for Protein Research, Osaka University (CR-19-05) and under the Cooperative Research Project Program of Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA Center), University of Tsukuba. Author contributions are as follows. TN conceived the project. RT-S and TN designed the research. RT-S and RA prepared the target proteins and performed the crystallographic analysis. MKK and YK produced the antibody. RO prepared the antibody fragment for structural analysis. KI supervised the EM work and MH obtained and analyzed the EM images. TM, YH and YA examined the enzymatic activity of the mutants. TE and MI performed the MD simulations. RT-S, RA and TN analyzed the data from structural and functional analysis. All of the authors contributed to paper preparation and TN compiled the paper. The corresponding author declares no financial or nonfinancial competing interests on the behalf of all authors.
Funding Information:
This research was partially supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI under Grant Nos. JP26291016, JP17K19206 and 19H03170 (to TN), JP19K06562 (to YH) and JP18H02404 (to YA), by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT; Grant No. 18H05426) (to MI), by the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED) under Grant No. JP16am0101020 (to TN), the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research; BINDS) from AMED under Grant Nos. 19am0101072j0003 (support number 0418) (to MH and KI), JP20am0101009 (support number 2633) (to MI), JP20am0101078 (support number 1948) (to YK), the Program for Promoting Research on the Supercomputer Fugaku (MD- Driven Precision Medicine) under Project ID hp200129, by the RIKEN Dynamic Structural Biology Project (to MI) and by AMED under Grant Nos. JP20am0401013 and JP20ae0101028 (to YK).
Publisher Copyright:
© 2021.
PY - 2021/5/1
Y1 - 2021/5/1
N2 - Antibody labeling has been conducted extensively for structure determination using both X-ray crystallography and electron microscopy (EM). However, establishing target-specific antibodies is a prerequisite for applying antibody-Assisted structural analysis. To expand the applicability of this strategy, an alternative method has been developed to prepare an antibody complex by inserting an exogenous epitope into the target. It has already been demonstrated that the Fab of the NZ-1 monoclonal antibody can form a stable complex with a target containing a PA12 tag as an inserted epitope. Nevertheless, it was also found that complex formation through the inserted PA12 tag inevitably caused structural changes around the insertion site on the target. Here, an attempt was made to improve the tag-insertion method, and it was consequently discovered that an alternate tag (PA14) could replace various loops on the target without inducing large structural changes. Crystallographic analysis demonstrated that the inserted PA14 tag adopts a loop-like conformation with closed ends in the antigen-binding pocket of the NZ-1 Fab. Due to proximity of the termini in the bound conformation, the more optimal PA14 tag had only a minor impact on the target structure. In fact, the PA14 tag could also be inserted into a sterically hindered loop for labeling. Molecular-dynamics simulations also showed a rigid structure for the target regardless of PA14 insertion and complex formation with the NZ-1 Fab. Using this improved labeling technique, negative-stain EM was performed on a bacterial site-2 protease, which enabled an approximation of the domain arrangement based on the docking mode of the NZ-1 Fab.
AB - Antibody labeling has been conducted extensively for structure determination using both X-ray crystallography and electron microscopy (EM). However, establishing target-specific antibodies is a prerequisite for applying antibody-Assisted structural analysis. To expand the applicability of this strategy, an alternative method has been developed to prepare an antibody complex by inserting an exogenous epitope into the target. It has already been demonstrated that the Fab of the NZ-1 monoclonal antibody can form a stable complex with a target containing a PA12 tag as an inserted epitope. Nevertheless, it was also found that complex formation through the inserted PA12 tag inevitably caused structural changes around the insertion site on the target. Here, an attempt was made to improve the tag-insertion method, and it was consequently discovered that an alternate tag (PA14) could replace various loops on the target without inducing large structural changes. Crystallographic analysis demonstrated that the inserted PA14 tag adopts a loop-like conformation with closed ends in the antigen-binding pocket of the NZ-1 Fab. Due to proximity of the termini in the bound conformation, the more optimal PA14 tag had only a minor impact on the target structure. In fact, the PA14 tag could also be inserted into a sterically hindered loop for labeling. Molecular-dynamics simulations also showed a rigid structure for the target regardless of PA14 insertion and complex formation with the NZ-1 Fab. Using this improved labeling technique, negative-stain EM was performed on a bacterial site-2 protease, which enabled an approximation of the domain arrangement based on the docking mode of the NZ-1 Fab.
KW - antibody labeling
KW - antibody-Assisted structural analysis
KW - electron microscopy
KW - epitope insertion
KW - protein crystallography.
UR - http://www.scopus.com/inward/record.url?scp=85105460270&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105460270&partnerID=8YFLogxK
U2 - 10.1107/S2059798321002527
DO - 10.1107/S2059798321002527
M3 - Article
C2 - 33950020
AN - SCOPUS:85105460270
SN - 0907-4449
VL - 77
SP - 645
EP - 662
JO - Acta Crystallographica Section D: Structural Biology
JF - Acta Crystallographica Section D: Structural Biology
ER -